Filed before 2025Filed 9 September 2021
Ankyra Therapeutics, Inc. raised $45M
Ankyra Therapeutics, Inc., a biotech company based in Boston, MA, raised $45M in a new equity round, according to a filing dated 9 September 2021.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 9 September 2021
- Round
- Equity round
- Amount sold
- $45M
- Offering size
- $45M
- Investors so far
- 14
- Based in
- Boston, MA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
3 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 79% of the 2,220 tracked raises with an amount filed in 2021, and than 63% of the 177 in biotech.
Ankyra Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 9 Sep 2021 | New filing | $45M | This raise |
| 15 May 2020 | New filing | $14.5M | Another raise |
More with Polaris on the board
- Auron Therapeutics, Inc.$7.12M
- MeridianMade, Inc.$20.3M
- ByHeart, Inc.$95.5M
- Icelandic Provisions, Inc.$7.08M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.